Cargando…
Transfermoral aortic valve implantation using self-expanding New Valve Technology (NVT) Allegra bioprosthesis: A pilot prospective study
BACKGROUND: Transcatheter aortic valve implantation (TAVI) has become a standard therapeutic option for patients with severe aortic stenosis (AS) at high cardiac surgical risk. The aim of the NAU-TILUS study was to investigate the safety and performance of the New Valve Technology (NVT) Allegra biop...
Autores principales: | Jagielak, Dariusz, Stanska, Aleksandra, Klapkowski, Andrzej, Brzezinski, Maciej, Kowalik, Maciej, Ciecwierz, Dariusz, Jaguszewski, Milosz, Fijalkowski, Marcin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169177/ https://www.ncbi.nlm.nih.gov/pubmed/30761515 http://dx.doi.org/10.5603/CJ.a2019.0019 |
Ejemplares similares
-
Transfermoral transcatheter aortic valve implantation using self-expanding Allegra bioprosthesis: One-year single-center outcomes
por: Milan, Joanna, et al.
Publicado: (2021) -
Sutureless aortic bioprosthesis: Competitor or alternative for transcatheter aortic valve implantation? Single center experience with Perceval valves
por: Olasińska-Wiśniewska, Anna, et al.
Publicado: (2022) -
Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance
por: Zuk, Grzegorz, et al.
Publicado: (2019) -
Allegra Transcatheter Heart Valve inside a Degenerated Sutureless Aortic Bioprosthesis
por: Vondran, Maximilian, et al.
Publicado: (2021) -
Optimal fluoroscopic viewing angles for stenting of the coronary aorto-ostial lesions
por: Targoński, Radosław, et al.
Publicado: (2021)